Treatment of genital lichen sclerosus in women--review

Ginekol Pol. 2012 Jun;83(6):458-61.

Abstract

Lichen sclerosus is a chronic inflammatory skin disorder that belongs to a group of autoimmune connective tissue diseases, localized within the skin and mucous membrane of the anogenital area. In the latter location, the focal atrophy of the mucosa is the most visible sign. Lesions may be accompanied by symptoms such as itching, pain, burning. The disease occurs more often in females. The etiology is not fully understood. Genetic, infectious, hormonal factors and autoimmune mechanisms are taken into consideration. Early diagnosis and appropriate treatment is important to avoid further complications. This review aims to analyze available literature on the treatment of this disease entity

Publication types

  • Review

MeSH terms

  • Dermatologic Agents / therapeutic use
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lichen Sclerosus et Atrophicus / diagnosis*
  • Lichen Sclerosus et Atrophicus / drug therapy*
  • Lichen Sclerosus et Atrophicus / prevention & control
  • Male
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Vulvar Lichen Sclerosus / diagnosis*
  • Vulvar Lichen Sclerosus / drug therapy*
  • Vulvar Lichen Sclerosus / prevention & control

Substances

  • Dermatologic Agents
  • Immunosuppressive Agents